Key result
Platform trials in perioperative medicine remain uncommon and methodologically diverse across 9 identified studies.
Why the study?
Traditional randomized controlled trials are often poorly suited to evaluating multiple, evolving clinical questions in anaesthesia and perioperative medicine.
Systematic Review (n=9)
Yes
Platform trials remain uncommon in anaesthesia and perioperative medicine, highlighting a need for greater consensus on nomenclature and methodological standards to realize their efficiency.
Platform trials remain uncommon and diverse in anaesthesia; leaves open the need for consensus on nomenclature and methods to improve efficiency.
Summary Background Traditional randomized control trials underpin evidence generation in anaesthesia and perioperative medicine, but are often poorly suited to evaluating multiple, evolving clinical questions. Platform trials encorporate a trial design that evaluates multiple interventions within one or more domains, is governed centrally using a master or core protocol, and has the capacity to add new research questions through the addition of new treatments and/or subgroup. Platform trials offer a flexible alternative, enabling the concurrent and sequential evaluation of multiple interventions and more efficient identification of effective or harmful treatments. Methods We conducted a scoping review using the Joanna Briggs Institute methodology, reported in accordance with PRISMA-ScR. Searches of bibliographic databases, grey literature and clinical trial registries (Ovid MEDLINE, Ovid Embase, Scopus, CINAHL Complete, Web of Science and the Cochrane Library) were undertaken. Records meeting an a priori definition of platform trials in anaesthesia or perioperative medicine were included. Trial design and methodological features were extracted and synthesised descriptively. Results Among 32 062 records identified, nine platform trials met eligibility criteria. Most were registered (8/9) and university-sponsored, with nearly half in the planning phase. All trials were multicentre, predominantly conducted in high-income countries and 44% involved international collaboration. Adult surgical populations were most commonly studied, with surgical site infection prevention being the leading perioperative focus. Across the nine platform trials, 24 interventions were evaluated, predominantly surgical (58.3%), followed by anaesthetic (12.5%). Adaptive features were universal, and Bayesian statistical methods predominated. Conclusions Platform trials remain uncommon and methodologically diverse in anaesthesia and perioperative medicine, reflecting early-stage adoption within an evolving field. Greater consensus regarding nomenclature, governance, and methodological standards, alongside expansion into anaesthesia-specific domains, is needed to realise their efficiency and ethical advantages.
No takes yet. Share an insight, caveat, or question.
Govender et al. (2026) conducted a systematic review in Anaesthesia and perioperative medicine (n=9). Platform trials was evaluated on Trial design and methodological features. A scoping review identified 9 platform trials evaluating 24 interventions in anaesthesia and perioperative medicine, showing that such trials remain uncommon and methodologically diverse.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: